Investigational Drug Information for Amonafide
✉ Email this page to a colleague
What is the development status for investigational drug Amonafide?
Amonafide is an investigational drug.
There have been 5 clinical trials for Amonafide.
The most recent clinical trial was a Phase 2 trial, which was initiated on June 1st 2007.
The most common disease conditions in clinical trials are Leukemia, Myeloid, Acute, Leukemia, Myeloid, and Leukemia. The leading clinical trial sponsors are Xanthus Pharmaceuticals, Inc., Antisoma Research, and National Cancer Institute (NCI).
Summary for Amonafide
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 3,111 |
| WIPO Patent Applications | 1,363 |
| Japanese Patent Applications | 581 |
| Clinical Trial Progress | Phase 2 (2007-06-01) |
| Vendors | 80 |
Recent Clinical Trials for Amonafide
| Title | Sponsor | Phase |
|---|---|---|
| A Pharmacokinetic and Efficacy Study of Amonafide L-malate (AS1413) in Combination With Cytarabine in Patients With Acute Myeloid Leukemia (AML) | Antisoma Research | Phase 2 |
| Phase III Randomized Study of Amonafide (AS1413) and Cytarabine Versus Daunorubicin and Cytarabine in Patients With Secondary Acute Myeloid Leukemia (AML)- the ACCEDE Study | Antisoma Research | Phase 3 |
| Amonafide in Combination With Cytarabine in Secondary AML | Xanthus Pharmaceuticals, Inc. | Phase 2 |
Clinical Trial Summary for Amonafide
Top disease conditions for Amonafide
Top clinical trial sponsors for Amonafide
US Patents for Amonafide
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
